Literature DB >> 12718466

Haemorrhagic smolt syndrome (HSS) in Norway: pathology and associated virus-like particles.

A Nylund1, H Plarre, K Hodneland, M Devold, V Aspehaug, M Aarseth, C Koren, K Watanabe.   

Abstract

Atlantic salmon Salmo salar pre-smolt, smolt and post-smolt, with clinical signs of haemorrhagic smolt syndrome (HSS) have been found in several locations along the Norwegian coast (Rogaland to Troms). Affected fish had pale gills and bleeding at the fin bases, but seemed to be in good physical condition with no obvious weight loss. The internal organs and body cavity showed distinct bleedings. Petechiae were found on the gastrointestinal tract, swim bladder and peritoneum, visceral adipose tissue, heart and somatic musculature. The liver was bright yellow and sometimes mottled with petechiae and ecchymoses. Acitic fluid was found in the visceral cavity and fluid was also present in the pericardial cavity. Histological examination revealed haemorrhage in most organs. The glomeruli were degenerated and the renal tubules were filled with erythrocytes. The aims of this study were to describe the pathology and discover, if possible, the aetiology of the HSS. Tissues were collected for light and transmission electron microscopy (TEM), immunofluorescence (IFAT), reverse transcription (RT)-PCR diagnostics (screening for infectious salmon anaemia virus [ISAV], viral haemorrhagic septicaemia virus [VHSV], salmon pancreas disease virus [SPDV], sleeping disease virus [SDV] and infectious haematopoetic necrosis virus [IHNV]), and tissue homogenates (heart, liver, kidney and spleen) were sterile-filtered and inoculated into cell cultures. Homogenates made from several tissues were also injected intraperitoneally into salmon and rainbow trout Oncorhynchus mykiss. The diagnostic tests revealed no consistent findings of any pathogens, with the exception of TEM which showed 2 types of virus-like particles: Type I was 50 to 60 nm in diameter and Type II about 50 nm in diameter. These virus-like particles were found in salmon from all farms affected by HSS and screened by TEM. Several different cells, blood vessel endothelial cells, endocardial cells, heart myofibres, and leukocytes were associated with the 2 virus-like particles. The Type I particle seems to be an infectious pancreatic necrosis (IPN)-like virus, while (based on the number of target cells, particle morphology, budding and uptake into target cells) Type II particle could be a togavirus.

Entities:  

Mesh:

Year:  2003        PMID: 12718466     DOI: 10.3354/dao054015

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  4 in total

1.  No influence of oxygen levels on pathogenesis and virus shedding in Salmonid alphavirus (SAV)-challenged Atlantic salmon (Salmo salar L.).

Authors:  Linda Andersen; Kjartan Hodneland; Are Nylund
Journal:  Virol J       Date:  2010-08-21       Impact factor: 4.099

2.  Infectious salmon anaemia virus (ISAV) in Chilean Atlantic salmon (Salmo salar) aquaculture: emergence of low pathogenic ISAV-HPR0 and re-emergence of virulent ISAV-HPR∆: HPR3 and HPR14.

Authors:  Marcos G Godoy; Molly J T Kibenge; Rudy Suarez; Eduardo Lazo; Alejandro Heisinger; Javier Aguinaga; Diego Bravo; Julio Mendoza; Katerina O Llegues; Rubén Avendaño-Herrera; Cristian Vera; Fernando Mardones; Frederick S B Kibenge
Journal:  Virol J       Date:  2013-11-23       Impact factor: 4.099

3.  Potential disease interaction reinforced: double-virus-infected escaped farmed Atlantic salmon, Salmo salar L., recaptured in a nearby river.

Authors:  A S Madhun; E Karlsbakk; C H Isachsen; L M Omdal; A G Eide Sørvik; Ø Skaala; B T Barlaup; K A Glover
Journal:  J Fish Dis       Date:  2014-01-27       Impact factor: 2.767

4.  Consequences of Haemorrhagic Smolt Syndrome (HSS) for the Immune Status of Atlantic salmon (Salmo salar L.) (Case Study).

Authors:  Aleksei Krasnov; Ingunn Sommerset; Tina Søfteland; Sergey Afanasyev; Preben Boysen; Hege Lund
Journal:  Biology (Basel)       Date:  2019-12-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.